Anika Therapeutics (ANIK) Share-based Compensation Growth (1y) (2011 - 2026)
Anika Therapeutics (ANIK) Share-based Compensation Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 26.47% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 47.06% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 8.79% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 281.05% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 92.83% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 5.49% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 61.54% |
| 10 | Anika Therapeutics | 198.50 Mn | 131.71 Mn | 19.00 Mn | -44.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.67% |
| Dec 31, 2025 | -145.15% |
| Sep 30, 2025 | -103.89% |
| Jun 30, 2025 | -28.96% |
| Mar 31, 2025 | 12,921.74% |
| Dec 31, 2024 | 214.35% |
| Sep 30, 2024 | -4.69% |
| Jun 30, 2024 | 10,293.33% |
| Mar 31, 2024 | 228.57% |
| Dec 31, 2023 | 11.54% |
| Sep 30, 2023 | -8.13% |
| Jun 30, 2023 | -99.26% |
| Mar 31, 2023 | -53.33% |
| Dec 31, 2022 | -431.21% |
| Sep 30, 2022 | 939.14% |
| Jun 30, 2022 | 537.66% |
| Mar 31, 2022 | 1,400.00% |
| Dec 31, 2021 | 230.34% |
| Sep 30, 2021 | -80.57% |
| Jun 30, 2021 | 841.18% |